Attitudes towards antidepressants among people living with inflammatory bowel disease: An online Australia-wide survey
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: Little research has been conducted on antidepressants (ADs) in inflammatory bowel disease (IBD) despite their widespread use and evidence that they may improve immunoregulatory activity. The present study aimed 1) To explore the use and type(s) of ADs currently prescribed to people living with IBD and to collect evidence with respect to any observed effect of ADs on the course of IBD, and 2) To explore experiences and opinions regarding the effect of ADs on IBD course and attitudes towards future trials with ADs. METHODS: A cross-sectional exploratory Australia-wide online survey was conducted. Numerical results of the survey were summarised using descriptive statistics and open-ended questions using a simple content analysis. RESULTS: Overall, 98 IBD respondents participated in the survey, 50% with Crohn's disease, and 79% females. Sixty five (66%) participants reported current and 46 (47%) reported past AD use. Of the current AD users, 51 (79%) reported that the symptoms ADs were prescribed for improved. Psychological well-being improved in 87% of participants. The majority of respondents observed no change in IBD activity while on ADs, however, 16 (25%) believed that ADs improved their IBD. Most (84%) respondents would recommend ADs to other people living with IBD, and 81% reported willingness to participate in clinical trials with ADs. CONCLUSIONS: Future clinical trials on ADs are warranted and likely to be accepted by people living with IBD in need of mental health care; however, it is yet unknown whether ADs will have a specific impact on long-term IBD activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20873 · Cited by 586
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A., & Moser, G. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106907.24881.f2 · Cited by 532
Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437
Graff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Jakul, L., McPhail, C., Ediger, J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.027 · Cited by 292
Fuller-Thomson, E., & Sulman, J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200608000-00005 · Cited by 292
Bennebroek Evertsz', F., Thijssens, N. A. M., Stokkers, P. C. F., Grootenhuis, M. A., Bockting, C. L. H., Nieuwkerk, P. T., & Sprangers, M. A. G. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.07.006 · Cited by 131
Sack, C., Phan, V. A., Grafton, R., Holtmann, G., van Langenberg, D. R., Brett, K., Clark, M., & Andrews, J. M. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.08.019 · Cited by 121
Self-citationMikocka-Walus, A. A., Turnbull, D. A., Andrews, J. M., Moulding, N. T., Wilson, I. G., Harley, H. A., Hetzel, D. J., & Holtmann, G. J. (2008) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-4-15 · Cited by 76
Self-citationMikocka-Walus, A. A., Turnbull, D., Holtmann, G., & Andrews, J. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22850 · Cited by 41
Self-citation
Research works printed but not linked: 9
- Bernstein, 2011, A prospective population-based study of triggers of symptomatic flares in IBD, Am J Gastroenterol, 105, 1994, 10.1038/ajg.2010.140 · DOI · Paper page
- Mercier, 2013, Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews, BMC Fam Pract, 14, 55, 10.1186/1471-2296-14-55 · DOI · Paper page
- Szuster-Ciesielska, 2003, In vitro immunoregulatory effects of antidepressants in healthy volunteers, Pol J Pharmacol, 55, 353
- Mikocka-Walus, 2006, Antidepressants and inflammatory bowel disease: a systematic review, Clin Pract Epidemol Ment Health, 2, 24, 10.1186/1745-0179-2-24 · DOI
- Mikocka-Walus, 2009, Can antidepressants influence the course of inflammatory bowel disease (IBD)? The current state of research, Eur J Gastroenterol Hepatol, 5, 48
- Mikocka-Walus, 2007, “It doesn't do any harm, but patients feel better”: a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease, BMC Gastroenterol, 7, 38, 10.1186/1471-230X-7-38 · DOI · Paper page
- Mikocka-Walus, 2012, A magic pill? A qualitative analysis of patients' views on the role of antidepressants in inflammatory bowel disease (IBD), BMC Gastroenterol, 20, 93, 10.1186/1471-230X-12-93 · DOI · Paper page
- Mackner, 2011, Psychoneuroimmunologic factors in inflammatory bowel disease, Inflamm Bowel Dis, 17, 849, 10.1002/ibd.21430 · DOI · Paper page
- Goodhand, 2012, Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study, Inflamm Bowel Dis, 18, 1232, 10.1002/ibd.21846 · DOI · Paper page
Cited by
Antidepressants in Inflammatory Bowel Disease: A Systematic Review
Macer, B. J. D., Prady, S. L., & Mikocka-Walus, A. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001059 · Cited by 92
Self-citationYanartas, Ö., Kani, H. T., Bicakci, E., Kilic, I., Banzragch, M., Acikel, C., Atug, O., Kuscu, K., Imeryuz, N., & Akin, H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s106039 · Cited by 69
“In terms of evidence-based medicine, the specific impact of antidepressant agents on long-term IBD activity and biologic parameters is still unknown and debatable.(33) Future prospective double-blind studies with a longer follow-up period are needed to address this issue.”
BackgroundResultTarricone, I., Regazzi, M. G., Bonucci, G., Rizzello, F., Carini, G., Muratori, R., Poggioli, G., & Campieri, M. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.001 · Cited by 53
Empirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Hatamnejad, M. R., Baradaran Ghavami, S., Shirvani, M., Asghari Ahmadabad, M., Shahrokh, S., Farmani, M., Sherkat, G., Asadzadeh Aghdaei, H., & Zali, M. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980189 · Cited by 28
“Mikocka-Walus and Andrews (2014) (115) Cross-sectional 98 cases Most IBD patients reported no improvement in their symptoms following the SSRI treatment.”
Background
Metadata
- Authors
- Mikocka-Walus, A., & Andrews, J. M.
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04
- Volume
- 8
- Issue
- 4
- Pages
- 296-303
- ISSN
- 1873-9946 (ISSN-L)
- OpenAlex
- W2008802907
- Cited by
- 18
- References
- 12
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attitudes towards antidepressants among people living with inflammatory bowel disease: An online Australia-wide survey. https://app.cochat.ai/papers/10.1016/j.crohns.2013.09.002
- The paper
- Mikocka-Walus, A., & Andrews, J. M. (2014). Attitudes towards antidepressants among people living with inflammatory bowel disease: An online Australia-wide survey. Journal of Crohn's and Colitis. https://doi.org/10.1016/j.crohns.2013.09.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.